LALPATHLAB and VIJAYA, both in Medical/Nursing Services. Monthly data through 2026-10-09. Change the comparison →
Share price change since Sep '21, the first month all 2 have a price: LALPATHLAB +5%, VIJAYA +152%.
Rebased at 2021-09. Monthly closes from each company's history.
Months with a missing value are left as gaps.
The share price return over 3 years, split into net profit growth, share count change and the change in P/E.
LALPATHLAB: share price rose 60% over 3 years: +80 pts from net profit growth, −19 pts from the P/E change, −1 pts from share count change.
VIJAYA: share price rose 145% over 3 years: +137 pts from net profit growth, +10 pts from the P/E change, −2 pts from share count change.
Segments are percentage points of the price return: price = P/E × net profit ÷ share count. These are the same numbers each company's own page shows.
Each cell is the company's percentile rank among its own sector peers that month. Darker is higher-ranked. Rows marked ↓ are inverted (lower debt, shorter cash cycle and a lower P/E rank higher).
Percentiles use today's listed companies in the sector and need at least 5 peers with a value.
| Metric | LALPATHLAB | VIJAYA |
|---|---|---|
| Share Price | ₹1933.60 | ₹1436.60 |
| Market Cap | ₹32415 cr | ₹14772 cr |
| P/E | 59.5x | 76.5x |
| P/B | 13.1x | 15.7x |
| P/S | 11.7x | 18.3x |
| ROCE | 29.0% | 22.0% |
| ROE | 22.0% | 20.5% |
| Operating margin | 31.0% | 43.0% |
| Revenue (TTM), indexed to 100 | ₹2771 cr | ₹808 cr |
| Net Profit (TTM) | ₹545 cr | ₹193 cr |
| Debt / Equity | 0.1x | 0.4x |
| Cash Conversion Cycle | -79d | -114d |
| Promoter holding | 53.2% | 52.5% |
| FII Holding | 17.4% | 11.7% |
| DII Holding | 21.6% | 31.6% |
| 12M momentum | 23.3% | 45.3% |
| Drawdown from Peak | -4.5% | -5.4% |
| Cash conversion (3Y) | 1.2x | 1.5x |
| Interest cover | 30.6x | 8.6x |
| Share Count Change (1Y) | 100.0% | 0.0% |
| Volatility (1Y) | 28.4% | 32.4% |
Latest month in the data: 2026-10. Highlight marks the higher value, or the lower value for P/E, P/B, P/S, debt, working-capital days, share count change and volatility. It marks a number, not a better investment.
Comparison is descriptive and historical. Highlights mark the higher or lower value on a metric, not a better investment. Not investment advice; ApnaFunda is not a SEBI-registered research analyst.